University Hospital Cologne

Clinical research in ophthalmology focuses on geographic atrophy secondary to age-related macular degeneration, with studies designed to explore whether new treatments can slow disease progression and protect vision.

• Evaluating potential therapies for geographic atrophy linked to age-related macular degeneration
• Assessing the effect of new approaches on lesion growth and eye disease progression
• Improving treatment options for advanced retinal disease

These trials aim to support better care for people facing progressive vision loss and to expand the range of available eye disease treatments.

The hematology research program includes studies in immune-mediated thrombotic thrombocytopenic purpura and related thrombotic microangiopathy conditions, with a focus on improving safety and treatment effectiveness in acute care settings.

• Testing new treatment options for immune-mediated thrombotic thrombocytopenic purpura
• Studying therapies for thrombotic microangiopathy and closely related blood disorders
• Evaluating how well emerging treatments are tolerated in urgent clinical situations

This work at University Hospital Cologne supports efforts to improve outcomes in rare but serious blood disorders.

In mental health research, the site is studying schizophrenia, with trials aimed at understanding whether new therapies can improve cognitive function and daily functioning for adults living with the condition.

• Assessing treatments intended to improve cognitive impairment in schizophrenia
• Exploring better ways to support thinking and memory symptoms
• Evaluating the overall usefulness of new psychiatric therapies

These studies reflect a broader effort to advance care in psychiatry by addressing both symptoms and quality of life.